Scabies Management in Pediatric Patients

First‑Line Pharmacologic Therapy

• Permethrin 5 % cream is the recommended first‑line treatment for all pediatric patients, including infants, children, and adolescents. The CDC’s 2015 MMWR recommendations endorse its use across age groups. 1

Age‑Specific Application Guidelines

• Infants and young children (≤ 2 years) should receive permethrin applied to the entire body, including scalp, hairline, forehead, temples, and neck. This differs from the adult‑only neck‑down application. 1
• Children ≥ 10 years (or ≥ 15 kg) may apply permethrin from the neck down only, unless immunocompromised. 1

Contraindicated or Cautioned Therapies

• Oral ivermectin is contraindicated in children weighing < 15 kg or younger than 10 years because of potential blood‑brain barrier penetration and neurotoxicity. 1
• Lindane should never be used in children < 10 years due to a high risk of seizures and neurotoxicity. 1
• Ivermectin must be taken with food to ensure adequate bioavailability; taking it on an empty stomach markedly reduces absorption. 1

Treatment of Special Populations

• Pregnant or lactating women should be treated with permethrin 5 % cream; ivermectin lacks sufficient safety data in pregnancy and is only “low‑risk” based on limited human data. 1
• Crusted (Norwegian) scabies requires combination therapy: daily permethrin for 7 days then twice weekly, plus oral ivermectin on days 1, 2, 8, 9, and 15, with mandatory specialist consultation. 1

Contact and Environmental Management

• All household members, close contacts, and sexual partners within the prior month must be treated simultaneously, even if asymptomatic, to prevent reinfection. 1
• Bedding, clothing, and towels should be machine‑washed and dried on hot cycles; alternatively, items can be dry‑cleaned or isolated from skin contact for ≥ 72 hours because scabies mites cannot survive off‑host for longer than that period. 2
• Fumigation of living areas is not required for scabies eradication. 1

Expected Post‑Treatment Course and Retreat Criteria

• Pruritus and rash may persist for up to 2 weeks after successful therapy due to allergic dermatitis, not treatment failure. 1
• Retreatment is indicated only after 2 weeks if live mites are observed, symptoms persist beyond 2 weeks, or new lesions continue to appear. An alternative regimen should be used in such cases. 1

Institutional Outbreak Management

• During outbreaks, the entire at‑risk population should be treated concurrently. Mass oral ivermectin is recommended for its ease of administration. [1][2]
• Outbreak response should involve specialist consultation to coordinate treatment and control measures. 1

Alternative Topical Options (when permethrin unavailable or fails)

• Sulfur 6 % ointment applied nightly for 3 consecutive nights (wash off before each re‑application).
• Crotamiton 10 % cream applied nightly for 2 nights, washed off 24 hours after the second application – shows ~60 % cure at 4 weeks versus ~89 % for permethrin.
• Benzyl benzoate 25 % – ~87 % cure rate but associated with burning sensation in ~43 % of patients.

(Alternative agents are presented without citation because they lack a referenced source in the provided text.)

Scabies Treatment Guidelines

First-line Treatment Options

• The American Academy of Pediatrics recommends topical 5% permethrin cream as the first-line treatment for uncomplicated scabies, applied from the neck down, left on for 8-14 hours, and then washed off, with one application generally being curative 3
• Oral ivermectin (200 μg/kg, repeated in 2 weeks) is an effective alternative first-line treatment, but not recommended for children weighing less than 15 kg due to potential neurotoxicity 3, 4

Special Populations

• The Centers for Disease Control and Prevention recommends permethrin as the preferred treatment for pregnant or lactating women due to limited safety data for ivermectin in these populations 3, 5
• The American Academy of Pediatrics recommends permethrin for infants and young children, and advises against using ivermectin in children weighing less than 15 kg 3, 4

Crusted (Norwegian) Scabies

• The Centers for Disease Control and Prevention recommends combination therapy for crusted scabies, including 5% topical permethrin cream and oral ivermectin 200 μg/kg on days 1, 2, 8, 9, and 15 3, 5, 6

Management of Contacts and Environment

• The Centers for Disease Control and Prevention advises that all persons with close personal, sexual, or household contact within the preceding month should be examined and treated if infested 3, 5

Follow-Up and Treatment Failure

• The Centers for Disease Control and Prevention notes that rash and pruritus may persist for up to 2 weeks after successful treatment, and considers retreatment after 2 weeks if symptoms persist or live mites are observed 3, 5

Treatment Pitfalls to Avoid

• The Centers for Disease Control and Prevention advises avoiding lindane due to risks of neurotoxicity, especially in children <10 years, pregnant women, and those with extensive dermatitis 3, 4, 5

Management of Scabies in Infants Less Than 2 Months Old

Treatment Recommendations

• The Centers for Disease Control and Prevention (CDC) and American Academy of Pediatrics do not use ivermectin in infants less than 2 months old due to potential neurotoxicity 7
• The CDC recommends that all household members, caregivers, and close contacts within the preceding month be examined and treated simultaneously, even if asymptomatic, to prevent reinfection 8
• Environmental decontamination can be achieved by machine washing and drying all bedding, clothing, and towels using hot cycles, or dry cleaning, and fumigation of living areas is unnecessary 8
• The CDC advises against using lindane in infants less than 2 months due to the risk of neurotoxicity, especially after bathing or in those with extensive dermatitis 8
• Benzyl alcohol lotion and malathion are not recommended for infants less than 2 months old 7

Follow-Up and Expected Course

• The CDC recommends reevaluating infants after 1-2 weeks if symptoms persist, and considering retreatment only if live mites are observed or symptoms persist beyond 2 weeks 8

Guideline Recommendations for Scabies Involving the Penis

First‑Line Topical Therapy

• The Centers for Disease Control and Prevention (CDC) recommends applying permethrin 5 % cream to the entire body from the neck down—including the penis, scrotum, and all genital folds—for 8–14 hours (typically overnight) and then washing it off; a single application is generally curative. 9
• Permethrin 5 % cream is the CDC‑endorsed first‑line treatment for scabies at any body site, including genital involvement. 10

Alternative Oral Therapy

• Oral ivermectin 200 µg/kg is an effective alternative to topical permethrin and should be repeated after 2 weeks when needed. 10
• Ivermectin is especially useful when topical application is impractical (e.g., in institutional outbreaks). 10

Contact Management & Environmental Decontamination

• All sexual partners and household contacts from the preceding month should be treated simultaneously, even if asymptomatic, to prevent reinfestation. 9
• Bedding, clothing, and towels must be machine‑washed and dried on a hot cycle or isolated from skin contact for at least 72 hours to eliminate mites. 10
• Routine fumigation of living areas is unnecessary for scabies control. 9

Expected Post‑Treatment Course & Management of Persistent Symptoms

• Post‑treatment pruritus and rash may continue for up to 2 weeks due to allergic dermatitis and do not indicate treatment failure. 10
• Retreatment is warranted only if live mites are observed after 14 days or if symptoms persist beyond 2 weeks; in such cases, switching between permethrin and ivermectin is recommended. 10
• Premature retreatment within the first 2 weeks, based solely on persistent itching, should be avoided. 10

Treatments to Avoid

• Lindane should not be used in children younger than 10 years, pregnant or lactating individuals, or patients with extensive dermatitis because of the risk of neurotoxicity (e.g., seizures) and aplastic anemia. 9
• Applying lindane after bathing increases systemic absorption and toxicity and must be avoided. 9
• Although inexpensive, lindane has the highest toxicity profile among scabicidal agents and is therefore discouraged. 9

Common Pitfalls (Cited)

• Failure to treat asymptomatic sexual partners is a frequent cause of reinfection and treatment failure. 10